Biobanks and the Return of Research Results: Out with the Old and in with the New?

Parks A. , “10 Ideas Changing the World Right Now: Biobanks,” Time, March 12, 2009, available at <http://www.time.com/time/specials/packages/article/0,28804,1884779_1884782_1884766,00.html> (last visited August 29, 2011).

Center of Genomics and Policy, P3G Lexicon - Popgen, available at <http://www.p3gobservatory.org/lexicon/list.htm> (last visited August 31, 2011).

Chalmers D. Nicol D. , “Human Genetic Research Databases and Biobanks: Towards Uniform Terminology and Australian Best Practice,” Journal of Law & Medicine 15, no. 4 (2008): 538–55.

Zawati M. H. Van Ness B. Knoppers B. M. , “Incidental Findings in Genomic Research: A Review of International Norms,” GenEdit 9, no. 1 (2011): 1–8.

Gibbons S. M. C. , “Are UK Genetic Databases Governed Adequately?” Legal Studies 27, no. 2 (2007): 312–342.

BBC News Health, “Biobank Reaches Its 500,000 Volunteer Target,” available at <http://www.bbc.co.uk/news/10546240> (last visited August 31, 2011).

Knoppers B. M. , “Return of Individual Results: Why the Fuss?” GRAVITAS 43, no. 4 (2010): 17–18.

Kolker E. , “Special Issue on Data-Intensive Science,” OMICS: A Journal of Integrative Biology 15, no. 4 (2011): 197–98.

Cho M. K. , “Understanding Incidental Findings in the Context of Genetics and Genomics,” Journal of Law, Medicine & Ethics 36, no. 2 (2008): 280–285.

See, e.g., LifeGene Ethics Group, Lifegene Ethics Policy Ver. 4.3 , 2010, available at <https://www.lifegene.se/Page-Files/104/20100916_LifeGene_Ethics_Policy4.3.docx> (last visited August 29, 2011).

See, e.g., CARTaGENE, Information Brochure for Participants , Université de Montréal, available at <http://www.cartagene.qc.ca/images/stories/cartagene_brochure.pdf> (last visited August 29, 2011).

See, e.g., Generation Scotland, Scottish Family Health Study FAQs , available at <http://www.generationscotland.org/index.php?option=com_content&view=article&id=41&Itemid=6> (last visited September 21, 2011); Generation Scotland, FAQs - Being a Volunteer, available at <http://www.generationscotland.org/index.php?option=com_content&view=article&id=43&Itemid=50> (last visited September 21, 2011).

Wallace S. Kent A. , “Population Biobanks and Returning Individual Research Results – Mission Impossible or New Directions?” Human Genetics Journal 130, no. 4 (2011): 393–401.

See, e.g., UK Biobank Ethics and Governance Council, Ethics and Governance Framework , 2007, available at <http://www.ukbiobank.ac.uk/docs/EGFlatestJan20082.pdf> (last visited August 29, 2011).

See, e.g., CARTaGENE, supra note 11.

See, e.g., ALSPAC Ethics and Law Committee, Policy Guidance Regarding Divulging Biomedical Information to Individual Participants , University of Bristol, 2010, available at <http://www.bristol.ac.uk/alspac/documents/divulgingbiomed.pdf> (last visited August 29, 2011).

Knoppers B. M. Kharaboyan L. , “‘Deconstructing’ Biobank Communication of Results,” SCRIPTed 6, no. 3 (2009): 677–684.

Wolf S. M. Lawrenz F. P. Nelson C. A. Kahn J. P. Cho M. K. Clayton E. W. Fletcher J. G. , “Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations,” Journal of Law, Medicine & Ethics 36, no. 2 (2008): 219–248.

Wolf S. M. Crock B. N. Van Ness B. , “Managing Incidental Findings & Research Results in Genomic Research Involving Biobanks & Archived Datasets,” Genetics in Medicine 2012 (in press).

Khoury M. J. , “The Case for a Global Human Genome Epidemiology Initiative,” Nature Genetics 36, no. 10 (2004): 1027–1028.

Council of Europe, Recommendation Rec(2006)4 of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin , Strasbourg, 2006, available at <https://wcd.coe.int/ViewDoc.jsp?id=977859> (last visited August 29, 2011).

Public Population Project in Genomics (P3G) Secretariat, available at <www.p3g.org/secretariat> (last visited August 29, 2011).

Ontario Health Study, Participant Consent Form, available at <https://ontariohealthstudy.ca/files/B4%20Consent%20Form%20ENG.pdf> (last visited August 29, 2011).

LifeGene Ethics Group, Lifegene Ethics Policy Ver. 4.3 , 2010, available at <https://www.lifegene.se/Page-Files/104/20100916_LifeGene_Ethics_Policy4.3.docx> (last visited August 29, 2011).

See ALSPAC Ethics and Law Committee, supra note 16.

Knoppers B. M. Abdul-Rahman (Zawati) M. H. , “Biobanks in the Literature,” in Elger B. , ed., Ethical Issues in Governing Biobanks: Global Perspectives (Ashgate Pub. Co., 2008): At 13–22, at 16.

See CARTaGENE, supra note 11.

UK Biobank, Ethics and Governance Framework version 3.0 , October 2007, available at <http://www.ukbiobank.ac.uk/docs/EGF20082.pdf> (last visited August 29, 2011).

See Generation Scotland, “FAQs,” supra note 12.

See ALSPAC Ethics and Law Committee, supra note 16.

See LifeGene Ethics Group, supra note 24.

See ALSPAC Ethics and Law Committee, supra note 16.

See LifeGene Ethics Group, supra note 24.

Estonian Genome Project, Gene Donor Consent Form , available at <http://www.geenivaramu.ee/index.php?id=104> (last visited August 29, 2011).

See Wallace Kent , supra note 13.

See Cho , supra note 9.

Centre of Genomics and Policy, Humgen International homepage, available at <http://www.humgen.org/int/index_lang.cfm?lang=2> (last visited August 29, 2011).

Singapore Bioethics Advisory Committee, Human Tissue Research Report, 2002.

Id., at s. 13.1.8.

Singapore Bioethics Advisory Committee, Ethical, Legal and Social Issues in Genetic Testing and Genetics Research: A Consultation Paper , Singapore, 2005, available at <http://www.bioethics-singapore.org/uploadfle/55211%20PMGT%20Research.pdf> (last visited September 21, 2011, See Annex D ).

Id., at s. 5, para. 5.1.

Bredenoord A. L. Kroes H. Y. Cuppen E. Parker M. van Delden J. J. M. , “Disclosure of Individual Genetic Data to Research Participants: The Debate Reconsidered,” Trends in Genetics 27, no. 2 (2010): 41–47.

Hansson M. G. , “A Minimal Ethical Framework for Biobank Research,” Methods in Biobanking, Methods in Molecular Biology 675 (2011): 39–59.

See UK Biobank, Ethics and Governance Framework, supra note 14.

Council for International Organizations of Medical Science (CIOMS) and World Health Organization (WHO), International Ethical Guidelines for Epidemiological Studies, 2009.

Id., at Commentary on Guideline 2.

Id., at Commentary on Guideline 5.

Johnston C. Kaye J. , “Does the UK Biobank Have a Legal Obligation to Feedback Individual Findings to Participants?” Medical Law Review 12, no. 3 (2004): 239–267.

Haga S. B. Beskow L. M. , “Ethical, Legal, and Social Implications of Biobanks for Genetics Research,” Advances in Genetics 60 (2008): 505–544.

See Knoppers Kharaboyan , supra note 17, at 678.

Ravitsky V. Wilfond B. S. , “Disclosing Individual Genetic Results to Research Participants,” American Journal of Bioethics 6, no. 6 (2006): 8–17.

Couzin-Frankel J. , “What Would You Do?” Science 331, no. 6018 (2011): 662–665.

Canadian College of Medical Geneticists and Canadian Association of Genetic Counselors, Joint Statement on the Process of Informed Consent for Genetic Research , Ottawa, 2008, available at <http://www.ccmg-ccgm.org/pdf/policy/2010/(22)%20CCMG_PosStmt_EPP_CAGCInformedConsent_16Jul2008.pdf> (last visited August 29, 2011).

Id., at s.7.

Organization for Economic Co-operation and Development, Guidelines for Human Biobanks and Genetic Research Databases (HBGRDs), Paris, 2009.

Western Australia Department of Health, Office of Population Health Genomics - Public Health Division, Guidelines for Human Biobanks, Genetic Research Databases and Associated Data, Perth, Australia, 2010.

Id., at Article 4.21.

Id., at Article 4.22.

Id., at Article 4.23.

See Knoppers , supra note 7, at 17.

Miller F. A. Christensen R. Giacomini M. , “Duty to Disclose What? Querying the Putative Obligation to Return Research Results to Participants,” Journal of Medical Ethics 34, no. 3 (2008): 210–213, at 212.

See Bredenoord , supra note 43, at 45.

See Miller , supra note 66.

See Bredenoord , supra note 43, at 45.

Office of Biorepositories and Biospecimens Research, National Cancer Institute, National Institutes of Health, Workshop on Release of Research Results to Participants in Biospecimen Studies, Workshop Summary, Bethesda, Maryland, March 4, 2011, at Recommendation 2.5.

Id., at 45.

Fabsitz R. , “Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group,” Cardiovascular Genetics 3, no. 6 (December 2010): 574–580, at 575.

See Couzin-Frankel , supra note 54, at 664.

See, e.g., Riegman P. van Veen E. , “Biobanking Residual Tissues,” Human Genetics 130, no. 3 (2011): 357–68. Tassé A. M. , “Biobanking and Deceased Persons,” Human Genetics, Special Issue on Biobanking 130, no. 3 (2011): 415–423; Hens K. Lévesque E. Dierickx K. , “Children and Biobanks: A Review of the Ethical and Legal Discussion,” Human Genetics 130, no. 3 (2011): 403–413.

Knoppers B. M. Zawati M. H. , “Population Biobanks and Access,” in Rodota S. Zatti P. , eds., Il Governo Del Corpo: Trattato Di Biodiritto (Giufrè Editore, 2011): 1181–1194; id.